Abstract:Background miRNAs are a group of small RNA molecules regulating target genes by inducing mRNA degradation or translational repression. Aberrant expression of miRNAs correlates with various cancers. Although miR-135a has been implicated in several other cancers, its role in breast cancer is unknown. HOXA10 however, is associated with multiple cancer types and was recently shown to induce p53 expression in breast cancer cells and reduce their invasive ability. Because HOXA10 is a confirmed miR-135a target in more than one tissue, we examined miR-135a levels in relation to breast cancer phenotypes to determine if miR-135a plays role in this cancer type. Methods Expression levels of miR-135a in tissues and cells were determined by poly (A)-RT PCR. The effect of miR-135a on proliferation was evaluated by CCK8 assay, cell migration and invasion were evaluated by transwell migration and invasion assays, and target protein expression was determined by western blotting. GFP and luciferase reporter plasmids were constructed to confirm the action of miR-135a on downstream target genes including HOXA10 . Results are reported as means ± S.D. and differences were tested for significance using 2-sided Student"s t-test. Results Here we report that miR-135a was highly expressed in metastatic breast tumors. We found that the expression of miR-135a was required for the migration and invasion of breast cancer cells, but not their proliferation. HOXA10 , which encodes a transcription factor required for embryonic development and is a metastasis suppressor in breast cancer, was shown to be a direct target of miR-135a in breast cancer cells. Our analysis showed that miR-135a suppressed the expression of HOXA10 both at the mRNA and protein level, and its ability to promote cellular migration and invasion was partially reversed by overexpression of HOXA10 . Conclusions In summary, our results indicate that miR-135a is an onco-miRNA that can promote breast cancer cell migration and invasion. HOXA10 is a target gene for miR-135a in breast cancer cells and overexpression of HOXA10 can partially reverse the miR-135a invasive phenotype.

MicroRNA-99a Inhibits Tumor Aggressive Phenotypes Through Regulating HOXA1 in Breast Cancer Cells.

<i>MiRNA-145-5p</i> Restrains Malignant Behaviors of Breast Cancer Cells Via Downregulating<i> H2AFX</i> Expression

MicroRNA-99a Suppresses Breast Cancer Progression by Targeting FGFR3.

Downregulation of Microrna 99a in Oral Squamous Cell Carcinomas Contributes to the Growth and Survival of Oral Cancer Cells.

Downregulated Mir-1247-5p Associates with Poor Prognosis and Facilitates Tumor Cell Growth Via DVL1/Wnt/β-catenin Signaling in Breast Cancer

microRNA-99a acts as a tumor suppressor and is down-regulated in bladder cancer

MicroRNA-99a Inhibits Hepatocellular Carcinoma Growth and Correlates with Prognosis of Patients with Hepatocellular Carcinoma

Mir-433 Inhibits Breast Cancer Cell Growth Via the MAPK Signaling Pathway by Targeting Rap1a

MicroRNA-193a inhibits breast cancer proliferation and metastasis by downregulating WT1

Tumor Suppressive Microrna-193B Promotes Breast Cancer Progression Via Targeting DNAJC13 and RAB22A.

MicroRNA-99 Family Members Suppress Homeobox A1 Expression in Epithelial Cells.

MiR-99a-5p regulates proliferation, migration and invasion abilities of human oral carcinoma cells by targeting NOX4.

miR-99a and -99b inhibit cervical cancer cell proliferation and invasion by targeting mTOR signaling pathway

MicroRNA-101 Inhibits Growth, Proliferation and Migration and Induces Apoptosis of Breast Cancer Cells by Targeting Sex-Determining Region Y-Box 2

Mirna-135A Promotes Breast Cancer Cell Migration and Invasion by Targeting HOXA10

Overexpression of Microrna-96-5p Inhibits Autophagy and Apoptosis and Enhances the Proliferation, Migration and Invasiveness of Human Breast Cancer Cells

Upregulation of Microrna‑1 Inhibits Proliferation and Metastasis of Breast Cancer

MicroRNA-99a Induces G1-phase Cell Cycle Arrest and Suppresses Tumorigenicity in Renal Cell Carcinoma

Tumor-promoting Properties of Mir-8084 in Breast Cancer Through Enhancing Proliferation, Suppressing Apoptosis and Inducing Epithelial–mesenchymal Transition

Microrna-99A is Downregulated and Promotes Proliferation, Migration and Invasion in Non-Small Cell Lung Cancer A549 and H1299 Cells.

Mir-96 Promotes Cell Proliferation, Migration and Invasion by Targeting PTPN9 in Breast Cancer.